A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.
- DOI
- 10.1242/dmm.036558
- Published
- 2019 Feb 7
- Container
- Disease models & mechanisms
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1242/dmm.036558,
title = {A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.},
author = {Delerue T and Tribouillard-Tanvier D and Daloyau M and Khosrobakhsh F and Emorine LJ and Friocourt G and Belenguer P and Blondel M and Arnauné-Pelloquin L},
year = {2019},
journal = {Disease models \& mechanisms},
doi = {10.1242/dmm.036558},
url = {https://doi.org/10.1242/dmm.036558}
}RIS
TY - JOUR TI - A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects. AU - Delerue T AU - Tribouillard-Tanvier D AU - Daloyau M AU - Khosrobakhsh F AU - Emorine LJ AU - Friocourt G AU - Belenguer P AU - Blondel M AU - Arnauné-Pelloquin L PY - 2019 JO - Disease models & mechanisms DO - 10.1242/dmm.036558 UR - https://doi.org/10.1242/dmm.036558 ER -
APA
T, D., D, T., M, D., F, K., LJ, E., G, F., P, B., M, B., & L, A. (2019). A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.. Disease models & mechanisms. https://doi.org/10.1242/dmm.036558
Source records
- pubmed · retrieved 2026-11-10T12:28:06.898Z